Last updated on April 2019

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder Including Suicidal Ideation in Pediatric Participants Assessed to be at Imminent Risk for Suicide

Contact Investigators or Research Sites near you

Start Over

Yale University

New Haven, CT United States
  Connect »

SIU School of Medicine

Springfield, IL United States
  Connect »

Lake Charles Clinical Trials

Lake Charles, LA United States
  Connect »

Sheppard Pratt Health System

Baltimore, MD United States
  Connect »

Wake Forest Baptist Medical Center

Winston-Salem, NC United States
  Connect »

Ohio State University

Columbus, OH United States
  Connect »

Hopital Erasme

Brussels, Belgium
  Connect »

CHU Saint-etienne

Saint-Priest-En-Jarez, France
  Connect »

Tennessee State University

Johnson City, TN United States
  Connect »

CHU Nantes

Nantes, France
  Connect »

Hosp. Sant Joan de Deu

Esplugues De Llobregat, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.